CrystalGenomics, Inc. 083790.KQ Stock
CrystalGenomics, Inc. Price Chart
CrystalGenomics, Inc. 083790.KQ Financial and Trading Overview
| CrystalGenomics, Inc. stock price | 3165 KRW |
| Previous Close | 4700 KRW |
| Open | 4800 KRW |
| Bid | 4915 KRW x 0 |
| Ask | 4920 KRW x 0 |
| Day's Range | 4510 - 4955 KRW |
| 52 Week Range | 2900 - 5950 KRW |
| Volume | 388.18K KRW |
| Avg. Volume | 769.91K KRW |
| Market Cap | 199.03B KRW |
| Beta (5Y Monthly) | 0.015554 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
083790.KQ Valuation Measures
| Enterprise Value | 216.12B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.421086 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 4.801 |
| Enterprise Value/EBITDA | -13.169 |
Trading Information
CrystalGenomics, Inc. Stock Price History
| Beta (5Y Monthly) | 0.015554 |
| 52-Week Change | 4.67% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5950 KRW |
| 52 Week Low | 2900 KRW |
| 50-Day Moving Average | 3870.7 KRW |
| 200-Day Moving Average | 3561.6 KRW |
083790.KQ Share Statistics
| Avg. Volume (3 month) | 769.91K KRW |
| Avg. Daily Volume (10-Days) | 729.18K KRW |
| Shares Outstanding | 40.45M |
| Float | 51.09M |
| Short Ratio | N/A |
| % Held by Insiders | 14.84% |
| % Held by Institutions | 10.10% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1.5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -64.56% |
| Operating Margin (ttm) | -43.28% |
| Gross Margin | 40.70% |
| EBITDA Margin | -36.45% |
Management Effectiveness
| Return on Assets (ttm) | -3.78% |
| Return on Equity (ttm) | -15.37% |
Income Statement
| Revenue (ttm) | 45.02B KRW |
| Revenue Per Share (ttm) | 655.98 KRW |
| Quarterly Revenue Growth (yoy) | -0.80% |
| Gross Profit (ttm) | 21.71B KRW |
| EBITDA | -16410873856 KRW |
| Net Income Avi to Common (ttm) | -29065261056 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 97.72B KRW |
| Total Cash Per Share (mrq) | 1449.7 KRW |
| Total Debt (mrq) | 81.06B KRW |
| Total Debt/Equity (mrq) | 40.82 KRW |
| Current Ratio (mrq) | 1.863 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -16297263104 KRW |
| Levered Free Cash Flow (ttm) | -17948536832 KRW |
Profile of CrystalGenomics, Inc.
| Country | South Korea |
| State | N/A |
| City | Seongnam-si |
| Address | Tower A, Korea Bio Park |
| ZIP | 463-400 |
| Phone | 82 3 1628 2700 |
| Website | https://www.cgxinc.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 65 |
CrystalGenomics, Inc., a biopharmaceutical company, discovers and develops structural chemoproteiomics-based drugs in Korea. Its lead development candidate is NSAID (CG100649), which is a tissue specific anti-inflammatory agent with cardiovascular, gastrointestinal, and renal safety profiles that has completed Phase IIa clinical trial. The company's drug candidates also include CG200745, a histone deacetylase inhibitor for cancer, which is in Phase I clinical trial; and CG400549, an antibiotic candidate for methicillin resistant staphylococcus aureus and vancomycin resistant staphylococcus aureus, which is in Phase I clinical trial. In addition, it offers cloning, expression, purification, and characterization of proteins of interest; and assay and structure services. The company has drug discovery collaborations with AstraZeneca, Daiichi-Sankyo, SBI-Biotech, Carna Biosciences, Yuyu Pharma, AmorePacific, Hanmi Pharmaceuticals, and ProQuest Investments. CrystalGenomics, Inc. was founded in 2000 and is headquartered in Seongnam, South Korea.
Q&A For CrystalGenomics, Inc. Stock
What is a current 083790.KQ stock price?
CrystalGenomics, Inc. 083790.KQ stock price today per share is 3165 KRW.
How to purchase CrystalGenomics, Inc. stock?
You can buy 083790.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CrystalGenomics, Inc.?
The stock symbol or ticker of CrystalGenomics, Inc. is 083790.KQ.
How many shares does CrystalGenomics, Inc. have in circulation?
The max supply of CrystalGenomics, Inc. shares is 76.54M.
What is CrystalGenomics, Inc. Price to Earnings Ratio (PE Ratio)?
CrystalGenomics, Inc. PE Ratio is now.
What was CrystalGenomics, Inc. earnings per share over the trailing 12 months (TTM)?
CrystalGenomics, Inc. EPS is 0 KRW over the trailing 12 months.